Actions

EuroStoxx 50 Rises 0.32% to 6,382.59 as Media Leads, Luxury Lags
European equities posted modest gains on Thursday, buoyed by hawkish comfort from Fed's Waller. Media stocks surged on a PepsiCo deal; luxury names slipped on weak China signals.

UBS Raises ASML Target to €2,350, Cites Best Risk/Reward in European Chips
Swiss bank upgrades outlook on ASML Holdings, calling it the most attractively valued semiconductor play in Europe as AI-driven energy demand creates a new sector dynamic.

Jefferies Keeps UBS at 'Buy', Sees Capital Rules Losing Bite
Jefferies maintains Buy rating on UBS with a 60-franc target, saying Swiss bank-regulation committee's moderate stance reduces capital-requirement risk for foreign subsidiaries.

Swiss Life Reports Strong First-Half 2026 Results, Fee Growth and Cost Cuts Ahead
Swiss Life Holding AG reported a 8% increase in net profit and fee revenue in the first half of 2026, while outlining plans to cut 600 jobs by year-end 2028.

Oura files for Nasdaq IPO, seeks valuation above $11bn
Health‑tracking ring maker Oura filed to list on Nasdaq, reporting $1.21bn revenue and $60.8m profit in the nine months to June.

Baader Bank cuts Siemens to Reduce, sees 12% downside on valuation
The bank said Siemens' valuation is running ahead of business development, with growth in its automation segment still to materialize.

Artisan Partners and investors call for Novartis board overhaul and tighter M&A oversight
Activist shareholder Artisan Partners and other major investors have urged Novartis to restructure its board and increase scrutiny of mergers and acquisitions after recent trial and deal setbacks.

RBC maintains UBS rating at Outperform with CHF 44 price target
RBC kept its Outperform rating on UBS and a CHF 44 target price, citing a Swiss Senate commission recommendation on banking regulation that could boost equity capital but may affect AT‑1 instruments.

J.P. Morgan rates Bytes Underweight, Bechtle Neutral on limited AI upside
J.P. Morgan initiates coverage of Bytes Technology Group and Bechtle, citing modest AI exposure and setting 2027 price targets of 375 pence and €38 respectively.

UBS cautious on SAP stock, flags slow AI agent progress
UBS warns that SAP shares, after a July rebound, face renewed pressure and cites limited advances in the company's AI agents as a concern.

FTSE 100 climbs 0.3% as oil prices surge amid Hormuz shipping slowdown
The FTSE 100 recovered from earlier losses, gaining 0.27% to 10,831.09, supported by a 1% rise in Brent crude as ship traffic through the Strait of Hormuz fell to its lowest level since May.

Swiss SMI slides over 1%, LVMH hits six‑year low, ABB leads gains
The Swiss market index fell to 14,221 as LVMH reached its lowest level since 2018, while ABB posted the biggest rise; USD/CHF slipped to 80.89 Rappen and US exchanges stayed closed for a holiday.

Sandoz and Oerlikon to outline strategy; Logitech and Nike hold AGMs on Sep 8
Swiss pharma group Sandoz and engineering firm Oerlikon will host investor days on Tuesday, while Logitech and Nike conduct their annual general meetings, drawing attention from global investors.

Le Groupe LU-VE annonce une hausse de 10 % des ventes au 1er semestre et réaffirme ses prévisions pour 2026
Les revenus du premier semestre 2026 se sont établis à 325,1 millions d'euros, le carnet de commandes a atteint 333,3 millions d'euros et la marge adjusted EBITDA a augmenté à 16,4 %, ce qui a poussé le fabricant italien de systèmes de climatisation à relever ses objectifs à moyen terme.
Goldman Sachs voit un potentiel de hausse de plus de 70 % pour l'indice KOSPI de Corée du Sud
Goldman Sachs maintient un objectif à 12 000 points pour le KOSPI, ce qui suppose plus de 70 % de hausse, malgré une baisse de 25 % depuis le sommet de juin 2026. Les perspectives sont basées sur la croissance des bénéfices de Samsung et de SK Hynix.

Ithaca Energy announces 11.4146 pence interim dividend
The UK North Sea producer declared a first interim dividend for 2026 of $255 million, equivalent to 11.4146 pence per share, payable on Sept. 24.

Eden Research sets AGM for 29 September
The AIM‑listed biotech firm will hold its annual general meeting at 10:00 a.m. in London and has released its 15‑month financial report covering the period to 31 March 2026.

Anthropic and OpenAI IPO plans may trigger early tax‑loss selling in large‑cap stocks
Evercore ISI expects mutual‑fund managers to accelerate tax‑loss harvesting after Labor Day to fund the $100 bn Anthropic and $60 bn OpenAI listings, targeting large‑cap equities that are down over 10% YTD.

Swiss equities slip as US markets close, Novartis drags index lower; USD/CHF falls
The SMI fell 1.2% to 14,221 points after Novartis lost 3.3% on a failed drug trial, while the franc edged higher to 80.89 per dollar and USD/JPY slipped to 154.07 yen.

JPMorgan says rising yields unlikely to derail equities as earnings momentum holds
JPMorgan analysts argue that strong earnings growth can keep equity markets buoyant despite U.S. debt topping $40 trillion and government yields near multi‑decade highs.

Coca-Cola Europacific Partners repurchases 258,500 shares
The beverage group bought back 258,500 ordinary shares between Aug. 31 and Sept. 4, cancelling them under its €1 billion buyback programme.

Barclays lifts stake in Central Asia Metals to 5.66%
Barclays increased its voting rights in Central Asia Metals to 5.66%, surpassing the UK major‑holdings notification threshold, with holdings split between ordinary shares and derivative instruments.

Swiss market slides as Novartis falls on failed drug trial, dollar weakens against franc
The SMI dropped over 1% to 14,221 points, led by a 3% slide in Novartis after negative Pelacarsen news, while the U.S. dollar fell to 80.89 rappen.

FINQ AIUP and AINT post 23% returns since launch, beating S&P 500
FINQ's AI-driven ETFs AIUP and AINT generated 23.5% and 23.8% returns from February to August 2026, more than double the S&P 500's 11.6% gain over the same period.

